Abstract:There have been many discussions on longevity from ancient times to the present day. In the Laozi, it is said, "Heaven and earth are long and enduring because they do not arise from themselves, so they can live forever." In Zhuangzi - Zai You, it is also said, "Keep your mental peace, and your body will be healthy. Don't strain your body and don't consume your spirit to live a long life." It is clear that people attach importance to anti-aging and the desire for longevity. Throughout human history, we have treated aging as an inevitable process, but with the development of medical science, we have become more aware of the various molecular changes in the human body. In an aging society, more people are suffering from age-related diseases such as osteoporosis, Alzheimer's disease, and cardiovascular disease, which has led to a search for anti-aging. However, by 'living longer' we mean not only living but also living longer in good health. The mechanisms of aging are still unclear and there is a great deal of interest and curiosity in how to combat aging effectively. Some potential criteria exist for the determination of anti-aging drugs: the first criterion is the ability to exert life-extending effects in model organisms, preferably in mammals; the second criterion is the ability to prevent or delay several age-related diseases in mammals; and the third criterion is the ability to inhibit the transition of cells from a quiescent to a senescent state. Based on these criteria, the current anti-aging drugs often involved are rapamycin, metformin, curcumin and other polyphenols, polysaccharides, resveratrol, etc. The most studied and relatively well-understood pathways and factors of aging are currently known to include seven enzymes, six biological factors, and one chemical, which mainly involve more than ten pathways such as Nrf2/SKN-1; NFκB; AMPK; P13K/AKT; IGF; and NAD.

[Research progress in drugs targeting 5-lipoxygenase for age-related diseases]

Advances in Research on the Relationship Between 5-Lipoxygenase and Atherosclerosis

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

5-Lipoxygenase inhibitors: a review of recent patents (2010 – 2012)

The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?

Effects and Mechanisms of Lutein on Aging and Age-Related Diseases

Arachidonic acid in aging: New roles for old players

Research progress on aging mechanism and drugs and the role of stem cells in anti-aging process

Progress in Understanding Oxidative Stress, Aging, and Aging-Related Diseases

5-Lipoxygenase Inhibition Protects Retinal Pigment Epithelium from Sodium Iodate-Induced Ferroptosis and Prevents Retinal Degeneration

Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution.

Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics as an Anti-Inflammatory Mechanism: A Systematic Review

Emerging Roles of 5-Lipoxygenase Phosphorylation in Inflammation and Cell Death

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

The aging lung: microenvironment, mechanisms, and diseases

Exploring the Expression Profiles of Serum Inflammatory Proteins and Potential Antiaging Targets in Chinese Long-Living People

Aging-Related Accumulation of Truncated Oxidized Phospholipids Augments Infectious Lung Injury and Endothelial Dysfunction via Cluster of Differentiation 36-Dependent Mechanism

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension

Development of 3,5-Dinitrobenzoate-based 5-Lipoxygenase Inhibitors.

Regulation of inflammation as an anti‐aging intervention

Lipoxygenase Metabolism: Critical Pathways in Microglia-mediated Neuroinflammation and Neurodevelopmental Disorders